People
Lyra Therapeutics names new chief medical officer
6 July 2022 - Lyra Therapeutics, Inc. (Nasdaq: LYRA), a US-based clinical-stage therapeutics company, announced on Tuesday that it has named Richard Nieman, MD as its new chief medical officer, effect...
DURECT Corporation names new chief financial officer
6 July 2022 - DURECT Corporation (Nasdaq: DRRX), a US-based biopharmaceutical company, announced on Tuesday that it has named Timothy M Papp as its new chief financial officer.In the new role, Papp wi...
Hu, Hermans Named to Ambrx Biopharma Board of Directors
5 July 2022 - - US-based biopharmaceutical company Ambrx Biopharma Inc., or Ambrx, (NYSE: AMAM), has appointed Edward Hu and Kate Hermans to its board of directors.

Edward Hu has mor...
Abbisko Therapeutics doses first patient in ABSK061 Phase one clinical trial
5 July 2022 - Abbisko Therapeutics Co., Ltd. (HKEX Stock Code: 2256.HK), a subsidiary of China-based Abbisko Cayman Limited (HKEX Stock Code: 2256.HK), announced on Monday that it has completed dosing...
ReviR Therapeutics names new chief scientific officer
4 July 2022 - ReviR Therapeutics, a US-based biotechnology company, announced on Friday that it has named Paul August, PhD as its new chief scientific officer.Dr August has over two decades of senior ...
Haas Named to Ligand Pharmaceuticals Board of Directors
30 June 2022 - - US-based biopharmaceutical company Ligand Pharmaceuticals Inc. (NASDAQ: LGND) has appointed Jason Haas to its board of directors, the company said.

Haas brings more than ...